ASML vs ATHR

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of 0/9, indicating severe deterioration in fundamental performance. Despite a strong gross margin of 70.79% and a low Debt/Equity ratio, the company is deeply unprofitable with negative operating and net margins exceeding -200%, and ROE of -135.60%. Valuation metrics are extremely elevated with a Price/Sales of 47.74 and no meaningful earnings, while the stock has declined over 40% in the past six months. Analyst coverage is minimal, insider sentiment is lukewarm, and the technical trend is bearish, reinforcing significant operational and market skepticism.